Exchange: NASDAQ·Updated 04:45 PM EDT
GOVX logo

GOVXGeovax Labs Inc

$0.98
$0.01
(1.01%)
Today
Closed $0.995
$0.015
(1.51%)
After Hours
Reported EarningsNov 13
Mkt Cap$5.13M
Vol72,333.00
News
all
press releases
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
More News
Why Is GOVX Stock Falling Today?
GeoVax announced the discontinuation of its development of a COVID-19 vaccine candidate and also came out with a share resale plan.
Stocktwits
Why Is GeoVax Labs Stock Falling Tuesday?
GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.read more...
Benzinga
GOVX Stock Soars 80%: Retail Traders Are Piling In As Ebola, Hantavirus Risks Resurface
CEO David A. Dodd said GEO-MVA remains central to GeoVax’s biodefense and vaccine supply strategy.
Stocktwits
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits
Emergent, Geovax, Tonix, Siga: Which Mpox-Linked Stocks Are Retail Investors Most Excited About?
Among the four U.S.-listed pharma stocks, retail investors are ‘extremely bullish’ on Emergent Biosolutions as it expressed readiness to scale up response efforts for the WHO health emergency.
Stocktwits
These Three Stocks are Experiencing an Outbreak– Or a Breakout Depending How you Look at it
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored
Geovax Labs Stock Keeps Soaring, Grabs Most Retail Attention As Mpox Concerns Grow
With another health agency issuing alerts about the rapidly spreading disease similar to smallpox, GOVX has seen its stock surge by more than 270% in the past week.
Stocktwits
<
1
2
...
>